Pengcheng Kang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 17
- MicroRNA in disease regulation 10
-
- RNA modifications and cancer 9
- Circular RNAs in diseases 8
- Surgery top 10%
- Cholangiocarcinoma and Gallbladder Cancer Studies 21
-
- Pancreatic and Hepatic Oncology Research 3
-
- Cancer Mechanisms and Therapy 4
-
- Liver physiology and pathology 2
- Journals
- PLoS ONE (1 paper)Scientific Reports (2 papers)International Journal of Molecular Sciences (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Pengcheng Kang
34 papers receiving 761 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 561
- Molecular Biology 575
- Surgery 287
- Oncology 99
- Complementary and alternative medicine 17
Countries citing papers authored by Pengcheng Kang
This map shows the geographic impact of Pengcheng Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengcheng Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengcheng Kang more than expected).
Fields of papers citing papers by Pengcheng Kang
This network shows the impact of papers produced by Pengcheng Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengcheng Kang. The network helps show where Pengcheng Kang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pengcheng Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 18 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 16 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 10 | |
| 10 | 2020 | 22 | |
| 11 | 2020 | 16 | |
| 12 | 2019 | 31 | |
| 13 | 2018 | 41 | |
| 14 | 2018 | 123 | |
| 15 | 2017 | 63 | |
| 16 | 2016 | 11 | |
| 17 | 2015 | 24 | |
| 18 | 2015 | 15 | |
| 19 | 2014 | 24 | |
| 20 | 2007 | 7 |
About Pengcheng Kang
Pengcheng Kang is a scholar working on Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 36 papers that have together received 764 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers), Cancer-related molecular mechanisms research (17 papers), MicroRNA in disease regulation (10 papers), RNA modifications and cancer (9 papers), Circular RNAs in diseases (8 papers), Cancer Mechanisms and Therapy (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Cancer Research (561 citations), Molecular Biology (575 citations) and Surgery (287 citations). Pengcheng Kang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yunfu Cui, Xiangyu Zhong, Xingming Jiang, Yi Xu, Kaiming Leng, Zhenglong Li, Zhidong Wang, Chunlong Li, Wei Qin and Ming Wan. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.